Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Iterum Therapeutics stock
Learn how to easily invest in Iterum Therapeutics stock.
Iterum Therapeutics is a biotechnology business based in the US. Iterum Therapeutics shares (ITRM) are listed on the NASDAQ and all prices are listed in US Dollars. Iterum Therapeutics employs 14 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Iterum Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ITRM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Iterum Therapeutics stock price (NASDAQ: ITRM)Use our graph to track the performance of ITRM stocks over time.
Iterum Therapeutics shares at a glance
|Latest market close||$0.97|
|52-week range||$0.60 - $7.02|
|50-day moving average||$1.20|
|200-day moving average||$2.02|
|Wall St. target price||$1.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.66|
Buy Iterum Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Iterum Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Iterum Therapeutics price performance over time
Historical closes compared with the close of $0.97 from 2023-03-29
|1 week (2023-03-24)||1.06%|
|1 month (2023-03-03)||-20.49%|
|3 months (2022-12-30)||15.48%|
|6 months (2022-09-30)||-40.12%|
|1 year (2022-03-29)||155.26%|
|2 years (2021-03-31)||-31.21%|
|3 years (2020-03-31)||2.71|
|5 years (2018-03-27)||N/A|
Iterum Therapeutics financials
|Gross profit TTM||$37,000|
|Return on assets TTM||-23.99%|
|Return on equity TTM||-113.59%|
|Market capitalisation||$12.6 million|
TTM: trailing 12 months
Iterum Therapeutics share dividends
We're not expecting Iterum Therapeutics to pay a dividend over the next 12 months.
Have Iterum Therapeutics's shares ever split?
Iterum Therapeutics's shares were split on a 1:15 basis on 17 August 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Iterum Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Iterum Therapeutics shares which in turn could have impacted Iterum Therapeutics's share price.
Iterum Therapeutics share price volatility
Over the last 12 months, Iterum Therapeutics's shares have ranged in value from as little as $0.601 up to $7.017. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iterum Therapeutics's is 1.6257. This would suggest that Iterum Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Iterum Therapeutics overview
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland. .
Iterum Therapeutics in the news
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2022 Earnings Call Transcript
Q4 2022 Iterum Therapeutics PLC Earnings Call
Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Frequently asked questionsWhat percentage of Iterum Therapeutics is owned by insiders or institutions?
Currently 1.026% of Iterum Therapeutics shares are held by insiders and 2.279% by institutions. How many people work for Iterum Therapeutics?
Latest data suggests 14 work at Iterum Therapeutics. When does the fiscal year end for Iterum Therapeutics?
Iterum Therapeutics's fiscal year ends in December. Where is Iterum Therapeutics based?
Iterum Therapeutics's address is: Fitzwilliam Court, Dublin, Ireland, 2 What is Iterum Therapeutics's ISIN number?
Iterum Therapeutics's international securities identification number is: IE00BF3W0Q35 What is Iterum Therapeutics's CUSIP number?
Iterum Therapeutics's Committee on Uniform Securities Identification Procedures number is: G6333L101
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert